Nasdaq - Delayed Quote USD

Virtus KAR Health Sciences A (RAGHX)

29.20 -0.04 (-0.14%)
At close: April 26 at 8:01 PM EDT

Top 10 Holdings (49.56% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 9.33%
UNH
UnitedHealth Group Incorporated 5.46%
IDXX
IDEXX Laboratories, Inc. 4.85%
ABBV
AbbVie Inc. 4.75%
COO
The Cooper Companies, Inc. 4.74%
ZTS
Zoetis Inc. 4.44%
MRK
Merck & Co., Inc. 4.11%
VRTX
Vertex Pharmaceuticals Incorporated 4.06%
WST
West Pharmaceutical Services, Inc. 3.96%
DHR
Danaher Corporation 3.86%

Sector Weightings

SectorRAGHX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 0.20%
Stocks 99.80%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average RAGHX Category Average
Price/Earnings 0.03 24.55
Price/Book 0.2 5.28
Price/Sales 0.35 2.06
Price/Cashflow 0.04 17.54
Median Market Cap 64,403.43 34,862.81
3 Year Earnings Growth 12.81 32.48

Bond Holdings

Performance & Risk

YTD Return 3.07%
5y Average Return 9.62%
Rank in Category (ytd) 17
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.88
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Virtus
Net Assets 151.31M
YTD Return 9.81%
Yield 0.00%
Morningstar Rating
Inception Date Feb 05, 2002

Fund Summary

The fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The portfolio manager considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences. The fund will invest primarily in common stocks and other equity securities.

Related Tickers